Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian-R Mackay

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 21, 2015
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 1, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Hepatology (Baltimore, Md.)|January 29, 2015
Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosisYongyin Li, Weibin Wang, Libo Tang, et al.
Hepatology (Baltimore, Md.)|January 30, 2007
AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockersYuki Moritoki, Zhe-Xiong Lian, Heike Wulff, et al.
The American Journal of Gastroenterology|September 30, 2015
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Hepatology (Baltimore, Md.)|September 16, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Clinics and Research in Hepatology and Gastroenterology|October 5, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Gut|September 17, 2015
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
The Journal of Experimental Medicine|April 26, 2006
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosisJunichiro Irie, Yuehong Wu, Linda S Wicker, et al.
Journal of Autoimmunity|August 1, 2006
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosisRoman Rieger, Patrick S C Leung, Melissa R Jeddeloh, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 21, 2015
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 1, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Hepatology (Baltimore, Md.)|January 29, 2015
Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosisYongyin Li, Weibin Wang, Libo Tang, et al.
Hepatology (Baltimore, Md.)|January 30, 2007
AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockersYuki Moritoki, Zhe-Xiong Lian, Heike Wulff, et al.
The American Journal of Gastroenterology|September 30, 2015
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Hepatology (Baltimore, Md.)|September 16, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Clinics and Research in Hepatology and Gastroenterology|October 5, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Gut|September 17, 2015
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
The Journal of Experimental Medicine|April 26, 2006
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosisJunichiro Irie, Yuehong Wu, Linda S Wicker, et al.
Journal of Autoimmunity|August 1, 2006
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosisRoman Rieger, Patrick S C Leung, Melissa R Jeddeloh, et al.
Pageof 8